Market revenue in 2023 | USD 36.5 million |
Market revenue in 2030 | USD 92.8 million |
Growth rate | 14.3% (CAGR from 2023 to 2030) |
Largest segment | Single-cell genomics |
Fastest growing segment | Single-Cell Metabolomics |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics, Single-Cell Metabolomics |
Key market players worldwide | Danaher Corp, 10x Genomics Inc Ordinary Shares - Class A, BD, PerkinElmer, ANGLE PLC, Illumina Inc, Bio-Rad Laboratories Inc, Standard BioTools Inc, Cytena, Cellenion, Mission Bio |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to single-cell omics market will help companies and investors design strategic landscapes.
Single-cell genomics was the largest segment with a revenue share of 46.03% in 2023. Horizon Databook has segmented the Spain single-cell omics market based on single-cell genomics, single-cell transcriptomics, single-cell proteomics, single-cell metabolomics covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of country-level data and insights on the Spain single-cell omics market , including forecasts for subscribers. This country databook contains high-level insights into Spain single-cell omics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account